Literature-searching strategies to improve the application of evidence-based clinical practice principles to stroke care

Mayo Clinic Proceedings

Volumn 79, Issue 10, 2004, Pages 1321-1329

  Demaerschalk, Bart M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AUTOMATION; BANDOLIER; BEST EVIDENCE; CASE REPORT; CEREBROVASCULAR DISEASE; CLINICAL EVIDENCE; CLINICAL PRACTICE; COCHRANE LIBRARY; CONFERENCE PAPER; CRITICALLY APPRAISED TOPIC; DARE; DATA BASE; EVIDENCE BASED MEDICINE; GRADE OF RECOMMENDATION; HEALTH TECHNOLOGY ASSESSMENT; HUMAN; INFOPOEMS; INFORETRIEVER; INFORMATION PROCESSING; INFORMATION RETRIEVAL; INTERNET; LEVEL OF EVIDENCE; MALE; MEDICAL LITERATURE; META ANALYSIS; NUMBER NEEDED TO HARM; NUMBER NEEDED TO TREAT; PARAMETER; PATIENT CARE; PRACTICE GUIDELINE; RESEARCH; SECONDARY PREVENTION; STROKE; SUMSEARCH; SYSTEMATIC REVIEW; THERAPY; TRIP;

EID: 4644312980     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/79.10.1321     Document Type: Conference Paper

References (53)

1. Al-Sadat A, Sunbulli M, Chaturvedi S. Use of intravenous heparin by North American neurologists: do the data matter? Stroke. 2002;33:1574-1577.
2. Halm EA, Chassin MR, Tuhrim S, et al. Revisiting the appropriateness of carotid endarterectomy. Stroke. 2003;34:1464-1471.
3. Gupta A, Thomas P. Stroke prevention: missed opportunities? Int J Clin Pract. 2002;56:338-341.
4. Holloway RG, Benesch C, Rush SR. Stroke prevention: narrowing the evidence-practice gap. Neurology. 2000;54:1899-1906.
5. Holloway RG Jr, Ringel SP. Narrowing the evidence-practice gap: strengthening the link between research and clinical practice [editorial]. Neurology. 1998;50:319-321.
6. Evidence-Based Medicine Working Group. Evidence-based medicine: a new approach to teaching the practice of medicine. JAMA. 1992;268:2420-2425.
7. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-Based Medicine: How to Practice and Teach EBM. 2nd ed. Edinburgh, Scotland: Churchill Livingstone; 2000:2-3, 87.
8. Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ. Do practice guidelines guide practice? the effect of a consensus statement on the practice of physicians. N Engl J Med. 1989;321:1306-1311.
9. Sibley JC, Sackett DL, Neufeld V, Gerrard B, Rudnick KV, Fraser W. A randomized trial of continuing medical education. N Engl J Med. 1982;306: 511-515.
10. Evans CE, Haynes RB, Birkett NJ, et al. Does a mailed continuing education program improve physician performance? results of a randomized trial in antihypertensive care. JAMA. 1986;255:501-504.
11. Davis DA, Thompson MA, Oxman AD, Haynes RB. Changing physician performance: a systematic review of the effect of continuing medical education strategies. JAMA. 1995;274:700-705.
12. Oxman AD, Guyatt GH. The science of reviewing research. Ann N Y Acad Sci. 1993;703:125-133.
13. Antmann EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A comparison of results of meta-analyses of randomized controlled trials and recommendations of clinical experts: treatments for myocardial infarction. JAMA. 1992;268:240-248.
14. Ramsey PG, Carline JD, Inui TS, et al. Changes over time in the knowledge base of practicing internists. JAMA. 1991;266:1103-1107.
15. Guyatt G, Rennie D, eds. Users' Guides to the Medical Literature: A Manual for Evidence Based Clinical Practice. Chicago, Ill: AMA Press; 2002.
16. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't [editorial]. BMJ. 1996;312:71-72.
17. Smith R. What clinical information do doctors need? BMJ. 1996;313: 1062-1068.
18. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-based Medicine: How to Practice and Teach EBM. Edinburgh, Scotland: Churchill Livingstone; 1997:1-20.
19. Smith R. Where is the wisdom...? [editorial]. BMJ. 1991;303:798-799.
20. McColl A, Smith H, White P, Field J. General practitioners' perceptions of the route to evidence based medicine: a questionnaire survey. BMJ. 1998; 316:361-365.
21. Demaerschalk B, Wiebe S. Evaluating the relevance of evidence based medicine in a neurology residency programme [abstract]. Can J Neurol Sci. 1998;25(suppl 2):S79. Abstract 7-13.
22. Oxford-Centre for Evidence Based Medicine. Levels of evidence and grades of recommendation. Available at: www.cebm.net/levels_of_evidence.asp. Accessibility verified August 23, 2004.
23. Jaeschke R, Guyatt G, Barratt A, et al. Therapy and understanding the results: measures of associaton. In: Guyatt G, Rennie D, eds. Users' Guides to the Medical Literature: A Manual for Evidence Based Clinical Practice. Chicago, Ill: AMA Press; 2002:359.
24. Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention: scientific review. JAMA. 2002;288:1388-1395.
25. Sandercock P, Mielke O, Liu M, Counsell C. Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack [Cochrane Review]. Cochrane Library. 2003;3. Available at: www.update-software.com/abstracts/ab000248.htm. Accessibility verified August 24, 2004.
26. Gorelick PB. Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy: an invited review. Stroke. 2002;33:862-875.
27. Dhar R, UWO Evidence Based Neurology Group. The combination of dipyridamole and aspirin was more efficacious than aspirin alone in the secondary prevention of stroke. Available at: www.uwo.ca/cns/ebn/PDFCATs/ stroke-aggrenox-asa-therapy.pdf. Accessibility verified August 24, 2004.
28. Kaye K, UWO Evidence Based Neurology Group. In patients with vascular risk factors, ramipril reduced the risk of stroke by 1.5%, NNT 67 (43-143) over a mean duration of four years. Available at: www.uwo.ca/cns/ebn /PDFCATs/stroke-prevention-ramipril.pdf. Accessibility verified August 24, 2004.
29. Sudlow C, Gubitz G, Sandercock P, Lip G. Stroke prevention. Clin Evid. 2003;9:221-245.
30. Cina CS, Clase CM, Haynes RB. Carotid endarterectomy for symptomatic carotid stenosis [Cochrane Review]. Cochrane Library. 2003;3. Available at: www.update-software.com/abstracts/ab001081.htm. Accessibility verified August 24, 2004.
31. SUMSearch database. Available at: http://sumsearch.uthscsa.edu/. Accessibility verified August 24, 2004.
32. TRIP database. Available at: www.tripdatabase.com. Accessibility verified August 24, 2004.
33. Evidence Based Medicine Reviews [Ovid Web site]. Available at: www.ovid.com/site/catalog/DataBase/904.jsp?top=2&mid=3&bottom= 7&subsection=10. Accessibility verified August 24, 2004.
34. InfoRetriever [InfoPOEMs Web site]. Available at: www.infopoems.com/ productinfo/infoRetrieverDetails.html. Accessibility verified August 24, 2004.
35. BMJ Publishing Group. Clinical Evidence Web site. Available at: www.clinicalevidence.com/ceweb/conditions/index.jsp. Accessibility verified August 24, 2004.
36. Best Evidence. Available at: www.acponline.org/journals/redirection .html. Accessed August 7, 2003.
37. Bandolier [serial online]. Available at: www.jr2.ox.ac.uk/bandolier/ index.html. Accessibility verified August 24, 2004.
38. Evidence-Based Neurology [University of Western Ontario Web site]. Available at: www.uwo.ca/clinns/ebn. Accessibility verified August 24, 2004.
39. Wiebe S, Demaerschalk B. Evidence based care in the neurosciences. Can J Neurol Sci. 2002;29:115-119.
40. MERIT Center: Mayo Clinic Scottsdale Evidence-Based Clinical Practice, Research, Informatics, and Training Web site. Available at: http://mcsweb/dept/ MERIT_Center/. Accessibility verified August 24, 2004.
41. Health Technology Assessment: a national R&D programme for the NHS [National Coordinating Centre for Health Technology Assessment Web site]. Available at: www.hta.nhsweb.nhs.uk/main.htm. Accessibility verified August 24, 2004.
42. National Guideline Clearinghouse. Available at: www.guideline.gov/. Accessibility verified August 24, 2004.
43. Canadian Practice Guidelines. Available at: www.cma.ca. Accessed August 7, 2003.
44. Cochrane Library: an introduction. Available at: www.cochrane.org/ reviews/clibintro.htm. Accessibility verified August 24, 2004.
45. Hankey GJ, Sudlow CLM, Dunbabin DW. Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients [Cochrane Review]. Cochrane Library. 2004;1. Available at: www.update-software.com/abstracts/ ab001246.htm. Accessibility verified August 24, 2004.
46. Chobanian AV, Bakris GL, Black HR, et al, National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report [published correction appears in JAMA. 2003;290:197]. JAMA. 2003;289:2560-2572.
47. Chobanian AV, Bakris GL, Black HR, et al, National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report [published correction appears in JAMA. 2003;290:197]. JAMA. 2003;289:2560-2572.
48. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L, Netherlands Epidemiology and Demography Compression of Morbidity Research Group. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med. 2003;138:24-32.
49. Hakim AA, Petrovitch H, Burchfield CM, et al. Effects of walking on mortality among nonsmoking retired men. N Engl J Med. 1998;338:94-99.
50. Kujala UM, Kaprio J, Sarna S, Koskenvuo M. Relationship between leisure-time physical activity and mortality: the Finnish twin cohort. JAMA. 1998;279:440-444.
51. Zyban for smoking cessation. Bandolier Review of: Hughes JR, Stead LF, Lancaster T. Anxiolytics and antidepressants for smoking cessation [Cochrane Review]. Cochrane Library. 2000;3. Available at: www.jr2.ox.ac.uk/bandolier/ band79/b79-3.html. Accessibility verified August 24, 2004.
52. Nicotine replacement therapy for stopping smoking. Bandolier Review of: Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation [Cochrane Review]. Cochrane Library. 2001;1. Available at: www.jr2.ox.ac.uk/bandolier/band86/b86-3.html. Accessibility verified August 24, 2004.
53. Toole JF, Malinow MR, Chambles LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004;291:565-575.